Clinical Trial Update: A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection [Phase 2]

View source ↗

Summary

Phase II study evaluating amitriptyline and mexiletine for painful neuropathy in HIV infection; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Peripheral Nervous System Disease

Drugs mentioned

• Mexiletine (Mexiletine)
• amitriptyline (amitriptyline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Peripheral Nervous System Disease | Phase 2 | Status: COMPLETED